Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
BörsenkürzelRDY
Name des UnternehmensDr Reddy's Laboratories Ltd
IPO-datumJan 01, 1986
CEOAghanian (Patrick)
Anzahl der mitarbeiter27811
WertpapierartDepository Receipt
GeschäftsjahresendeJan 01
Addresse8-2-337, Road No.3 Banjara Hills
StadtHYDERABAD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandIndia
Postleitzahl500-034
Telefon914049002900
Websitehttps://www.drreddys.com/
BörsenkürzelRDY
IPO-datumJan 01, 1986
CEOAghanian (Patrick)